Evaxion A/S
EVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001828253
No open-market purchases or sales by Evaxion A/S insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.93M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Evaxion A/S changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 9 | 8 | −1 |
| Shares | 1.33M | 1.33M | −3.20K (−0.2%) |
| Value | $3.27M | $5.00M | +$1.74M (+53.1%) |
New holders (1)
Institutions that held Evaxion A/S at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bessemer Group Inc | 18 | $0 | 0.00% |
Sold out (2)
Institutions that held Evaxion A/S at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Beacon Capital Management, LLC | 972 | $2.38K |
| Advisor Group Holdings, Inc. | 25 | $61 |